MOTS-c is the peptide built for the endurance research question. Its biology connects mitochondria, glucose handling, exercise response, and physical capacity.
A peptide for repeatable output
Endurance is sustained output and the ability to come back for the next session. In 10 young men, cycling increased endogenous MOTS-c in skeletal muscle and serum. In administered mouse studies, MOTS-c improved physical-capacity measures. Together, those findings make it the clearest peptide research match for repeatable training.
B12 matters when deficiency undermines training. NAD+ and Sermorelin answer different coenzyme and bedtime questions. The endurance verdict must come from repeated pace, power, completion, and recovery data.
What belongs in this collection
- MOTS-c: best matched to mitochondrial signaling and metabolic-fitness research.
- NAD+ formats: best matched to a direct NAD and cellular-energy routine.
- B12: best matched to a measured or strongly suspected B12 deficiency.
- Sermorelin: best matched to bedtime GH-signaling and recovery interest.
MOTS-c is the mitochondrial peptide in this set: a 16-amino-acid molecule encoded by a short open reading frame within mitochondrial 12S rRNA and detected in human skeletal muscle and circulation. Rebody's intended format is an injection vial. NAD+, B12, and Sermorelin address distinct pathways through their own formats, evidence, and instructions.
How the options differ
| Option | Biological question | Practical reason to choose it | Evidence boundary |
|---|---|---|---|
| MOTS-c injection | Mitochondrial and exercise-biology research | Closest experimental match to endurance intent | administered-human endurance results are not established |
| NAD+ formats | NAD-dependent cellular energy biology | Current route choices for a direct NAD+ routine | No route-specific proof of greater endurance |
| Methylcobalamin B12 injection | Vitamin B12 deficiency | First choice when low B12 limits energy | Deficiency evidence does not apply to everyone |
| Sermorelin formats | Bedtime GH-axis signaling | Current option when poor sleep is breaking training consistency | Not an endurance drug |
The routines differ across MOTS-c, NAD+, B12, and Sermorelin. Injection setup, storage, supplies, and refill timing can decide which choice stays consistent across a training block.
Why MOTS-c leads this search
Among MOTS-c, NAD+ formats, B12, Sermorelin, MOTS-c leads because its molecule and evidence are closest to the shopper's question. The evidence is specific: In 10 young men, a stationary-bike session increased the body's own MOTS-c in skeletal muscle and serum. That was human exercise physiology, not treatment with a MOTS-c injection. Experiments that administered MOTS-c and improved physical-capacity or metabolic measures used mice. A recruiting Phase 2a trial plans 120 adults with prediabetes and overweight or obesity, 12 weeks of subcutaneous MOTS-c or placebo, and an OGTT-derived insulin-sensitivity endpoint. Results are not posted.
What the research measured
The key distinction is administration. Cycling increased the participants’ own MOTS-c in a study of 10 young men; the experiments that administered MOTS-c and improved physical-capacity or metabolic measures were performed in mice. The 120-person Phase 2a trial is recruiting and has posted no results.
Consistency is the endpoint
Endurance is built across weeks of repeatable work. The practical question is not whether one session feels unusually energetic; it is whether pace, power, heart-rate response, session completion, and recovery stay stable enough to support the next planned session.
MOTS-c attracts endurance interest because mitochondria and glucose handling matter during prolonged exercise. The direct human finding is narrower: cycling increased endogenous MOTS-c in 10 young men. Administered capacity findings came from mice.
Separate adaptation from acute stimulation
A product that changes alertness can make a workout feel easier without changing aerobic adaptation. A hard block can make resting heart rate and perceived effort worse temporarily while fitness improves later. Judge a defined training period, not the first dose or a single leaderboard result.
Keep volume, intensity distribution, terrain, equipment, fueling, hydration, sleep, and heat exposure visible. Otherwise, normal training variability will be credited to the product.
Where the alternatives belong
B12 belongs when deficiency is contributing to fatigue or neurologic symptoms. NAD+ belongs to direct coenzyme interest, not an established endurance result. Sermorelin belongs to bedtime GH-axis signaling and recovery interest. MOTS-c is the only mitochondrial-derived peptide in this comparison.
MOTS-c’s final formulation, vial, schedule, supply, storage, and price are not published. Do not borrow a cycling protocol from a research retailer or turn the 12-week Phase 2a trial into an endurance schedule.
Consistency needs a four-week record, not a heroic session
Build the record around sessions that recur. For an easy aerobic day, capture duration, average pace or power, heart rate, perceived exertion, temperature, and fueling. For a threshold session, record the percentage of planned intervals completed and whether output faded. For the following day, record soreness, sleep, and willingness to train. The useful question is whether ordinary work becomes more repeatable across weeks.
That record distinguishes three things that marketing often merges. Acute stimulation can make one session feel easier. Training adaptation changes performance after repeated exposure and recovery. Better consistency means fewer missed or degraded sessions across a block. A product could plausibly affect one without affecting the others, so the endpoint must be named in advance.
MOTS-c currently has no administered-human endurance result. The human cycling study shows that exercise itself changes endogenous MOTS-c in 10 young men. Mouse experiments support further investigation of administered MOTS-c and physical capacity. The recruiting Phase 2a human study is testing insulin sensitivity, not race pace or weekly completion. None of those findings proves that runners or cyclists will train more consistently.
Before assigning a peptide explanation, audit the usual consistency killers: rapid load increases, low energy availability, iron or B12 deficiency, heat, poor sleep, illness, inadequate recovery, and an unrealistic plan. A cleaner plan is often the highest-leverage endurance intervention.
Questions endurance athletes ask
Will MOTS-c make zone-2 training easier?
That has not been demonstrated in administered-human research. The human cycling study measured the body’s own peptide response to exercise.
Why does MOTS-c attract endurance interest?
MOTS-c sits at the intersection of mitochondrial signaling, glucose handling, exercise-responsive human physiology, and administered physical-capacity findings in mice. The next evidence step is an administered-human result; current research already gives endurance interest a coherent biological basis.
Can B12 help endurance?
B12 can address deficiency. In someone whose B12 status is normal, the evidence does not make it a universal endurance enhancer.
Is NAD+ better before or after training?
The current evidence and product facts here do not establish a performance-specific before-versus-after winner. Follow the selected product label rather than inventing exercise timing.
Is MOTS-c banned for runners and cyclists?
MOTS-c is prohibited under the 2026 WADA list. Tested athletes should treat that as decisive.
A better endurance tracking sheet
Pick one or two repeatable sessions: for example, fixed power at a fixed duration, or a familiar route at controlled effort. Record average power or pace, heart rate, perceived exertion, completion, fueling, temperature, sleep, and recovery into the next day. Compare a block of sessions rather than cherry-picking the best one.
Stop interpreting the product if illness, injury, travel, altitude, a new training plan, or major calorie change overwhelms the comparison.
Safety and overreaching
Declining performance with persistent fatigue, disrupted sleep, rising resting heart rate, mood change, or recurrent illness may reflect excessive training load or another medical issue. Chest pain, fainting, severe shortness of breath, or neurologic symptoms need prompt evaluation.
Injection-site reactions remain relevant to future MOTS-c use, but the larger endurance mistake is using an experimental story to outrun recovery, fueling, or antidoping rules.
Choose MOTS-c for the endurance-research lane
MOTS-c is the peptide-first choice for endurance research because mitochondria, glucose handling, exercise response, and physical capacity all meet in its evidence story. Build the training block, track repeated output and recovery, and keep the WADA prohibition in view for tested athletes.
Keep reading
- Peptides for Exercise Capacity and Metabolic Fitness
- Workout-Recovery Peptides and Injections
- Is MOTS-C an Exercise Mimetic? Human Data vs Mouse Treatment Results